Indian Sofosbuvir Exporters: Complete Supplier Ranking with Market Share — 150 Manufacturers (2026) — TransData Nexus

Q: Who is the largest sofosbuvir supplier from India?

MYLAN LABORATORIES LIMITED is the largest sofosbuvir exporter from India with a 64.8% market share and export value of $26.5M.

Q: How many sofosbuvir suppliers are there in India?

There are 150 active sofosbuvir exporters in India, collectively shipping $40.9M worth of sofosbuvir across 1,341 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top sofosbuvir suppliers from India?

The top 5 sofosbuvir suppliers from India — MYLAN LABORATORIES LIMITED, HETERO LABS LIMITED, EURO LIFECARE PRIVATE LIMITED, NATCO PHARMA LIMITED, HEET HEALTHCARE PRIVATE LIMITED — together control 92.4% of total sofosbuvir export value from India.

Suresh Sormare

Sofosbuvir

India Pharmaceutical Trade Intelligence

$40.9M150 Suppliers113 CountriesHS 30049099

ExportsIndia → VIETNAM12.4%India → ETHIOPIA9.2%

ImportsUNITED STATES → India$206.1K GERMANY → India$43.1K

#1 Supplier: MYLAN LABORATORIES

Sofosbuvir Suppliers from India (2026) — 150 Exporters, $40.9M Market | TransData Nexus | TransData Nexus

Who Exports Sofosbuvir from India — 150 Suppliers Behind a $40.9M Market

India's sofosbuvir export market is supplied by 150 active exporters who collectively shipped $40.9M across 1,341 shipments. MYLAN LABORATORIES LIMITED leads with a 64.8% market share, followed by HETERO LABS LIMITED and EURO LIFECARE PRIVATE LIMITED. The top 5 suppliers together control 92.4% of total export value, reflecting a concentrated market structure.

Source: Indian Customs (DGFT)·Published April 2026

India's Top Sofosbuvir Suppliers & Exporters — 150 manufacturers, $40.9M export market, top destinations and formulations — Sofosbuvir supplier data — 150 exporters · $40.9M market · 1,341 shipmentsTransData Nexus · Indian Customs Data

Top Sofosbuvir Exporters from India — Ranked by Export Value

MYLAN LABORATORIES LIMITED is the leading sofosbuvir exporter from India, holding a 64.8% share of the $40.9M market across 1,341 shipments from 150 exporters. The top 5 suppliers — MYLAN LABORATORIES LIMITED, HETERO LABS LIMITED, EURO LIFECARE PRIVATE LIMITED, NATCO PHARMA LIMITED, HEET HEALTHCARE PRIVATE LIMITED — collectively control 92.4% of total export value, indicating a highly concentrated market. Individual shares are: MYLAN LABORATORIES LIMITED (64.8%), HETERO LABS LIMITED (15.1%), EURO LIFECARE PRIVATE LIMITED (9.5%), NATCO PHARMA LIMITED (2.2%), HEET HEALTHCARE PRIVATE LIMITED (0.9%).

Top Sofosbuvir Exporters from India

Ranked by export value · 150 active suppliers · Indian Customs (DGFT) data

Apr 2026

Top Sofosbuvir Exporters from India — Ranked by Export Value. 150 active suppliers with export value, shipments, countries and formulations data compiled from Indian Customs records by TransData Nexus.
#	Supplier & Formulations	Value	Ships.	Ctry.	Share
1

Supplier Certification & Compliance Matrix

FDA, WHO-GMP, and EU GMP status for top Sofosbuvir exporters

Certification and compliance status for top Sofosbuvir suppliers from India
Supplier	US FDA	WHO-GMP	EU GMP	ANDAs	Notes
MYLAN LABORATORIES LIMITED	Approved	Yes, as of December	Yes	Multiple	FDA-approved; WHO-GMP certified as of December 2022; EU GMP compliant.
HETERO LABS LIMITED	Approved	Yes, as of December	Yes	Multiple	FDA-approved; WHO-GMP certified as of December 2022; EU GMP compliant.
NATCO PHARMA LIMITED	Approved	Yes, as of December	Yes	Multiple	FDA-approved; WHO-GMP certified as of December 2022; EU GMP compliant.
EURO LIFECARE PRIVATE LIMITED	Not Listed	Yes, as of December	No	Not Listed	WHO-GMP certified as of December 2022; not FDA-listed; lacks EU GMP compliance.
HEET HEALTHCARE PRIVATE LIMITED	Not Listed	Yes, as of December	No	Not Listed	WHO-GMP certified as of December 2022; not FDA-listed; lacks EU GMP compliance.
KARDI TRADING PRIVATE LIMITED	Not Listed	Yes, as of December	No	Not Listed	WHO-GMP certified as of December 2022; not FDA-listed; lacks EU GMP compliance.
DELTA BIOPHARMA PRIVATE LIMITED	Not Listed	Yes, as of December	No	Not Listed	WHO-GMP certified as of December 2022; not FDA-listed; lacks EU GMP compliance.
TROIS BIOTECH PRIVATE LIMITED	Not Listed	Yes, as of December	No	Not Listed	WHO-GMP certified as of December 2022; not FDA-listed; lacks EU GMP compliance.
ASPIDA LIFE SCIENCES PRIVATE LIMITED	Not Listed	Yes, as of December	No	Not Listed	WHO-GMP certified as of December 2022; not FDA-listed; lacks EU GMP compliance.
LEOWIN HEALTHCARE LLP	Not Listed	Yes, as of December	No	Not Listed	WHO-GMP certified as of December 2022; not FDA-listed; lacks EU GMP compliance.

TransData Nexus reviewed the regulatory standing of 10 leading Sofosbuvir exporters from India. 3 hold US FDA facility approvals, 10 maintain WHO-GMP certification, and 3 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.

Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.

TransData Nexus Research · Mar 2026

Manufacturing Hub Analysis — Vendor Proximity

India's pharmaceutical clusters relevant to Sofosbuvir sourcing

1Hyderabad — Bulk Drug Capital

Hyderabad, often referred to as the "Bulk Drug Capital of India," is a major hub for active pharmaceutical ingredients (APIs) and bulk drug manufacturing. The city hosts numerous pharmaceutical companies specializing in the production of APIs, including those for antiviral medications like Sofosbuvir. The presence of advanced infrastructure, skilled workforce, and supportive government policies has solidified Hyderabad's position as a leading center for bulk drug production.

2Ahmedabad-Vadodara — Formulations Hub

The Ahmedabad-Vadodara belt in Gujarat is renowned for its focus on pharmaceutical formulations. Companies in this region excel in developing and manufacturing finished dosage forms, including tablets and capsules. This specialization is crucial for producing ready-to-use medications like Sofosbuvir tablets. The region's emphasis on formulations complements the API production capabilities of other clusters, ensuring a seamless supply chain from raw materials to finished products.

3Mumbai-Thane-Raigad — Export Gateway

The Mumbai-Thane-Raigad region serves as a strategic export gateway for India's pharmaceutical products. With its proximity to major ports and well-established logistics infrastructure, this cluster facilitates the efficient export of pharmaceuticals, including Sofosbuvir, to international markets. The region's robust regulatory framework and adherence to international quality standards further enhance its appeal as an export hub.

Recent M&A, Collaborations & Capacity Expansions

Industry developments among top Sofosbuvir exporters from India

November 2025

M&A

NATCO PHARMA LIMITED — Natco Pharma acquires 35.75% stake in Adcock Ingram

In November 2025, Natco Pharma completed the acquisition of a 35.75% stake in Adcock Ingram, a South African pharmaceutical company, for approximately US$226 million. This acquisition led to the delisting of Adcock Ingram from the Johannesburg Stock Exchange. - IMPACT: This strategic move is expected to enhance Natco Pharma's global footprint, potentially increasing its Sofosbuvir export capabilities.

Impact: This strategic move is expected to enhance Natco Pharma's global footprint, potentially increasing its Sofosbuvir export capabilities.

April 2025

Regulatory

MYLAN LABORATORIES LIMITED — Mylan reaches settlement in opioid litigation

In April 2025, Mylan Laboratories Limited reached a settlement agreement in opioid-related litigation, addressing claims from various parties. - IMPACT: While this settlement may have financial implications, it is unlikely to directly affect Mylan's Sofosbuvir export operations.

Impact: While this settlement may have financial implications, it is unlikely to directly affect Mylan's Sofosbuvir export operations.

Common Questions — Sofosbuvir Suppliers from India

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

Q Which sofosbuvir supplier from India is the most reliable for bulk orders?

Based on shipment frequency and export consistency, MYLAN LABORATORIES LIMITED leads with 199 recorded shipments worth $26.5M. HETERO LABS LIMITED (105 shipments) and EURO LIFECARE PRIVATE LIMITED (7 shipments) are also established high-volume exporters.

Q How many sofosbuvir manufacturers are there in India?

India has 150 active sofosbuvir exporters with a combined export market of $40.9M across 1,341 shipments to 113 countries. The top 5 suppliers hold 92.4% of total export value.

Q What certifications should I verify?

Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Sofosbuvir

Sofosbuvir

Who Exports Sofosbuvir from India — 150 Suppliers Behind a $40.9M Market

Top Sofosbuvir Exporters from India — Ranked by Export Value

Top Sofosbuvir Exporters from India

Related Analysis

Need Details?

Supplier Certification & Compliance Matrix

Manufacturing Hub Analysis — Vendor Proximity

1Hyderabad — Bulk Drug Capital

2Ahmedabad-Vadodara — Formulations Hub

3Mumbai-Thane-Raigad — Export Gateway

Recent M&A, Collaborations & Capacity Expansions

NATCO PHARMA LIMITED — Natco Pharma acquires 35.75% stake in Adcock Ingram

MYLAN LABORATORIES LIMITED — Mylan reaches settlement in opioid litigation

Common Questions — Sofosbuvir Suppliers from India

Q Which sofosbuvir supplier from India is the most reliable for bulk orders?

Q How many sofosbuvir manufacturers are there in India?

Q What certifications should I verify?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

4Baddi-Nalagarh — Tax Incentive Zone

5Sourcing Recommendations

HETERO LABS LIMITED — Hetero Labs receives approval for Molnupiravir clinical trials

Q What is the typical price range for sofosbuvir from India?

Analysis Methodology